This is what sparked Mostafa to launch Automata, which now provides software and hardware lab-automation solutions to enable efficiencies and scale in labs, working with customers including the NHS, Novartis, and Imperial College London. A recent partnership with the University Hospital Southampton NHS Foundation Trust aims to develop a strategy and plan to bring the benefits of automation to a number of disease areas, including prostate and cervical cancer screening.
Mostafa shares with me how his background in architecture brought him to where he is today, the challenges facing CEOs in the UK biotech industry in 2022, and his views on how the lab automation market is changing and growing.
Subscribe to the Tech Talks Daily Podcast
Why do so many of us feel busy all day, yet struggle to point to…
How do you protect millions in revenue during your busiest hour of the year when…
How do you design financial infrastructure that keeps running when the unexpected hits, whether that…
Have you ever wondered why “compliance” still gets treated like a slow, spreadsheet-heavy chore, even…
Can designing for human error become the strongest cybersecurity strategy in an AI-accelerated world? In…
At Davos this year, some of the biggest names in tech sent a clear signal.…